Lessons from the glitazones: a story of drug development
- 1 June 2001
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 357 (9271) , 1870-1875
- https://doi.org/10.1016/s0140-6736(00)04960-6
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonistsJournal of Clinical Investigation, 2000
- The glitazones: proceed with cautionWestern Journal of Medicine, 2000
- RosiglitazoneDrugs, 1999
- Troglitazone in Combination With Sulfonylurea Restores Glycemic Control in Patients With Type 2 DiabetesDiabetes Care, 1998
- PPARγ and colorectal carcinoma: Conflicts in a nuclear familyNature Medicine, 1998
- Hepatic Dysfunction Associated with TroglitazoneNew England Journal of Medicine, 1998
- Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes MellitusNew England Journal of Medicine, 1998
- Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes MellitusNew England Journal of Medicine, 1998
- Too soon to marketBMJ, 1997
- Therapeutic Comparison of Metformin and Sulfonylurea, Alone and in Various Combinations: A double-blind controlled studyDiabetes Care, 1994